Clinical Trial Update: Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 study assessing the combination of chemotherapy with inotuzumab ozogamicin in patients with B-cell acute lymphoblastic leukemia, including Philadelphia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-negative B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Besponsa (inotuzumab ozogamicin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Lymphoblastic Leukemia in Remission, B Acute Lymphoblastic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2021-04-13